Herpes simplex virus: an occupational hazard in dentistry

被引:24
作者
Lewis, MAO [1 ]
机构
[1] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales
关键词
herpes simplex virus; herpes labialis; herpetic whitlow; keratitis; infection; antiviral therapy; education; dental;
D O I
10.1111/j.1875-595X.2004.tb00263.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Approximately 70% of the population in the western world become infected with the herpes simplex virus type 1 (HSV-1) by the second decade of life. This review discusses the role of the HSV-1 as a potential occupational hazard for dental workers, focusing on herpes labialis, herpetic Whitlow and keratitis. The risks associated with the dental treatment of patients with HSV-1, both from the perspective of the clinician and the patient are presented. Procedures for minimising the impact of HSV-1 within the dental practice, in particular infection control, delivery of treatment and patient education, are addressed. The management options for recurrent herpes labialis are also reviewed.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 43 条
[1]   Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy [J].
Bacon, TH ;
Levin, MJ ;
Leary, JJ ;
Sarisky, RT ;
Sutton, D .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :114-+
[2]   Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis [J].
Bacon, TH ;
Boon, RJ ;
Schultz, M ;
Hodges-Savola, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3042-3044
[3]  
Blondeau J M, 1990, J Can Dent Assoc, V56, P785
[4]   Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey [J].
Boon, RJ ;
Bacon, TH ;
Robey, HL ;
Coleman, TJ ;
Connolly, A ;
Crosson, P ;
Sacks, SL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :324-325
[5]  
*BRIT MED ASS ROY, 2002, BRIT NAT FORM, V44
[6]   Resistant herpes simplex virus type 1 infection:: An emerging concern after allogeneic stem cell transplantation [J].
Chen, Y ;
Scieux, C ;
Garrait, V ;
Socié, G ;
Rocha, V ;
Molina, JM ;
Thouvenot, D ;
Morfin, F ;
Hocqueloux, L ;
Garderet, L ;
Espérou, H ;
Sélimi, F ;
Devergie, A ;
Leleu, G ;
Aymard, M ;
Morinet, F ;
Gluckman, E ;
Ribaud, P .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :927-935
[7]   Survey of resistance of herpes simplex virus to acyclovir in northwest England [J].
Christophers, J ;
Clayton, J ;
Craske, J ;
Ward, R ;
Collins, P ;
Trowbridge, M ;
Darby, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :868-872
[8]  
*GLAX, 2002, VALTR PRESCR INF
[9]   Growth of herpes simplex type 1 on skin explants of atopic eczema [J].
Goodyear, HM ;
Davies, JA ;
Mcleish, P ;
Buchan, A ;
Skinner, GRB ;
Wither, M ;
Harper, JI .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1996, 21 (03) :185-189
[10]  
GREENWOOD D, 2003, ANTIBIOT CHEMOTHER, P11